The global influenza virus infection market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period (2022-2028). Increased awareness of the impact of influenza on human health, and the corresponding increase in R&D activities for the launch of novel medications, are two of the key factors for the market growth. Due to the seriousness and possible risk of influenza, various governmental and non-governmental organizations have launched influenza awareness campaigns. As a result of these endeavors, there is a higher awareness of the need for new treatment alternatives.
To Request a Sample of our Report on Influenza Virus Infection Market: https://www.omrglobal.com/request-sample/influenza-virus-infection-market
Additionally, major agencies such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), have sponsored and continue to undertake flu awareness programs. With a robust pipeline of vaccines, prominent market companies, and significant government support, therapeutically effective vaccinations have become more accessible. For instance, in May 2021, Seqirus, which is developing a cell-based quadrivalent seasonal influenza vaccine for children aged six months to four years, announced positive phase-Ill clinical data results. On the other hand, the impact of strict regulatory requirements combined with a lengthier time frame for conducting clinical trials is expected to hamper product development.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Treatment
- By Influenza Type
- By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Genentech, Inc., Shionogi & Co., Ltd., Seqirus, Biocryst Pharmaceutical, Inc., GlaxoSmithKline plc., and others.
(Get 15% Discount on Buying this Report)
A full Report of Influenza Virus Infection Market is Available @ https://www.omrglobal.com/industry-reports/influenza-virus-infection-market
Global Influenza Virus Infection Market Report Segment
By Treatment
- Baloxavir Marboxil
- Oseltamivir Phosphate
By Influenza Type
- Influenza A
- Influenza B
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Influenza Virus Infection Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott
- Alvogen
- Amneal Pharmaceuticals LLC
- Autoimmune Technologies, LLC
- ContraFect Corp.
- Lupin Pharmaceuticals, Inc.
- Macleods Pharmaceuticals Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vir Biotechnology, Inc.
- Zydus Pharmaceuticals, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
